Akturk HK, Karakus KE, Mason E, Yilmaz ZY, Garg SK, Cengiz D. Association of HbA1c with Time in Range, Time in Tight Range, Empirically Derived Continuous Glucose Monitoring Glucose Ranges, and Mean Glucose. Diabetes Technol Ther. 2026 Oct 12;:15209156261496613. [Epub ahead of print] PubMed PMID: 42861851
Polsky S, Beck E, Shah A, Cengiz D, Garg SK. Incident Diabetic Retinopathy after Adjunctive Tirzepatide Treatment for 1 Year in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2026 Jul 14;:15209156261468108. [Epub ahead of print] PubMed PMID: 42452840
Akturk HK, Mason E, Cengiz D, Karakus KE, Garg SK. Patient-Reported Adverse Events with Adjunctive Tirzepatide or Semaglutide Treatment in Adults with Type 1 Diabetes. Diabetes Technol Ther. 2026 Jun;28(6):614-618. PubMed PMID: 41804758
Akturk HK, Karakus KE, Cengiz D, Mason E, Beck E, Kaur G, Garg SK. Glucose Control and Continuous Glucose Monitoring Metrics During 12 Months of Treatment with Tirzepatide in Overweight or Obese Patients with Type 1 Diabetes. Diabetes Technol Ther. 2026 Mar;28(3):193-200. PubMed PMID: 41804540
